Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Evoke Pharma Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 13 | −9 |
| Shares | 2.00M | 70.5K | −1.93M (−96.5%) |
| Value | $987.0K | $228.0K | −$759.0K (−76.9%) |
New holders (4)
Institutions that held Evoke Pharma Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 812 | $3.00K | 0.00% |
| Group One Trading, L.P. | 746 | $2.00K | 0.00% |
| Bank of America Corp | 125 | $0 | 0.00% |
| Harbor Investment Advisory, LLC | 83 | $0 | 0.00% |
Sold out (13)
Institutions that held Evoke Pharma Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 108,545 | $54.0K |
| State Street Corp | 82,645 | $41.0K |
| Cornerstone Capital, Inc. | 66,000 | $33.0K |
| Northern Trust Corp | 42,121 | $21.0K |
| Virtu Financial LLC | 42,793 | $21.0K |
| Wambolt & Associates, LLC | 32,000 | $15.0K |
| Renaissance Technologies LLC | 28,200 | $14.0K |
| Pure Financial Advisors, Inc. | 17,647 | $9.00K |
| Laird Norton Trust Company, LLC | 11,000 | $5.00K |
| Morgan Stanley | 6,224 | $3.00K |
| Spire Wealth Management | 5,000 | $2.00K |
| Simplex Trading, LLC | 3,042 | $1.00K |
| FMR LLC | 47 | $0 |